Economics of Multiple Sclerosis Disease-Modifying Therapies in the USA
Daniel M. Hartung
Topics & Concepts
Glatiramer acetateMedicineAlemtuzumabMultiple sclerosisFingolimodEconomic impact analysisTeriflunomideCost effectivenessActuarial scienceBusinessEconomicsPsychiatryInternal medicineRisk analysis (engineering)MicroeconomicsTransplantationMultiple Sclerosis Research StudiesHealth Systems, Economic Evaluations, Quality of LifePeripheral Neuropathies and Disorders